Abbott gets US FDA nod for Proclaim Plus SCS system to deliver FlexBurst360 therapy
The new Proclaim Plus spinal cord stimulation (SCS) system can be used in conjunction with Abbott's NeuroSphere Virtual…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 Aug 22
The new Proclaim Plus spinal cord stimulation (SCS) system can be used in conjunction with Abbott's NeuroSphere Virtual…
24 Aug 22
The funds will be used by Digital Diagnostics to advance its product roadmap, increase the reach of its…
24 Aug 22
The ClarityDX Prostate test offers patients and doctors an accurate prediction of clinically relevant prostate cancer for better…
24 Aug 22
The Digital LightCycler System intends to support laboratories doing sensitive and accurate DNA and RNA analysis in fields…
24 Aug 22
PiCSO-AMI-II will be the second major randomized trial to evaluate the role of PiCSO in improving coronary microvascular…
23 Aug 22
The US-based vitro diagnostics company will offer the MonkeyPox testing at Provista’s Alpharetta, Georgia-based CLIA/CAP certified laboratory, which…
23 Aug 22
Spear Bio aims to commercialise its initial assay to reliably measure the amounts of SARS-CoV-2-neutralising antibodies in dried-blood…
23 Aug 22
Omnipod 5 is the first tubeless AID System cleared in the U.S. for preschool children
23 Aug 22
The suture-less solution for surgical repair is anticipated for patient use in 2023
23 Aug 22
Company applauds FDA ruling providing improved accessibility and reduced costs to Americans seeking hearing health